Alglucerase injection is as an enzyme replacement therapy in patients diagnosed with type I Gaucherís disease, a genetic disorder with symptoms and signs of anemia or bleeding tendency, liver disorder, and bone disease.
Adults and children 2 years of age and older.
IV - Initial dosage may be as little as 2.5 units/kg 3 times a week upto 60 units/kg as frequently as once a week or as infrequently as every 4 week.
It comes as a solution for injection to be administered by a healthcare provider into the vein.
ē Caution should be exercised in patients with history of prostate cancer, any allergy, children especially less than 10 years old, during pregnancy and breastfeeding.
ē Monitor liver function, kidney function, and blood counts regularly while taking this medication.
ē Extreme caution needed in children less than 2 years of age.
ē Local :
Discomfort, itching, burning, swelling and pus.
ē Miscellaneous : Fever, abdominal discomfort, nausea, vomiting, fatigue, weakness, headache, swelling in the extremities and diarrhea.
Avoid excess dosage.
Store it in refrigerator (2 - 8įC).
Subscribe to our Free Newsletters!